Clinical trial
Prospective Interventional Study Evaluating the Modulation of Bile Acid Profiles, Gut Microbiome and Liver Health Through Lifestyle Adjustments in Individuals at High Risk of Developing Liver Cancer.
NCT07111130 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Interventional Study Evaluating the Modulation of Bile Acid Profiles, Gut Microbiome and Liver Health Through Lifestyle Adjustments in Individuals at High Risk of Developing Liver Cancer.
- Lead sponsor
- National Cancer Centre, Singapore
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- March 31, 2028
- Enrollment
- 90 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.